SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Medivir AB Announces Initiation of the Second Cohort of the Interferon-Free Phase II Study Combining Simeprevir and Sofosbuvir for Hepatitis C Treatment